Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brice

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Medical Oncology (Northwood, London, England)|June 29, 2000
Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patientsI Ionescu, P Brice, D Simon, et al.
Cancer|August 16, 2001
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trialP Brice, P Colin, F Berger, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Transplantation|March 21, 1998
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemiaV Meignin, A Devergie, P Brice, et al.
Bone Marrow Transplantation|February 16, 2000
Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up studyD Decaudin, N Brousse, P Brice, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patientsC Fermé, E Lepage, P Brice, et al.
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Leukemia & Lymphoma|February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literatureP Pautier, A Devidas, A Delmer, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Medical Oncology (Northwood, London, England)|June 29, 2000
Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patientsI Ionescu, P Brice, D Simon, et al.
Cancer|August 16, 2001
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trialP Brice, P Colin, F Berger, et al.
European Journal of Haematology. Supplementum|July 13, 2005
How to define intermediate stage in Hodgkin's lymphoma?C Gisselbrecht, N Mounier, M André, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Transplantation|March 21, 1998
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemiaV Meignin, A Devergie, P Brice, et al.
Bone Marrow Transplantation|February 16, 2000
Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up studyD Decaudin, N Brousse, P Brice, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patientsC Fermé, E Lepage, P Brice, et al.
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Leukemia & Lymphoma|February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literatureP Pautier, A Devidas, A Delmer, et al.
Pageof 15